132 related articles for article (PubMed ID: 18520068)
1. Radiosynthesis and biodistribution in mice of a 18F-labeled analog of O-1302 for use in cerebral CB1 cannabinoid receptor imaging.
Nojiri Y; Ishiwata K; Qinggeletu ; Tobiishi S; Sasada T; Yamamoto F; Mukai T; Maeda M
Biol Pharm Bull; 2008 Jun; 31(6):1274-8. PubMed ID: 18520068
[TBL] [Abstract][Full Text] [Related]
2. Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
Tobiishi S; Sasada T; Nojiri Y; Yamamoto F; Mukai T; Ishiwata K; Maeda M
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1213-7. PubMed ID: 17666847
[TBL] [Abstract][Full Text] [Related]
3. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
Horti AG; Fan H; Kuwabara H; Hilton J; Ravert HT; Holt DP; Alexander M; Kumar A; Rahmim A; Scheffel U; Wong DF; Dannals RF
J Nucl Med; 2006 Oct; 47(10):1689-96. PubMed ID: 17015906
[TBL] [Abstract][Full Text] [Related]
4. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.
Mathews WB; Scheffel U; Finley P; Ravert HT; Frank RA; Rinaldi-Carmona M; Barth F; Dannals RF
Nucl Med Biol; 2000 Nov; 27(8):757-62. PubMed ID: 11150708
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
Willis PG; Pavlova OA; Chefer SI; Vaupel DB; Mukhin AG; Horti AG
J Med Chem; 2005 Sep; 48(18):5813-22. PubMed ID: 16134948
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.
Donohue SR; Varnäs K; Jia Z; Gulyás B; Pike VW; Halldin C
Bioorg Med Chem Lett; 2009 Nov; 19(21):6209-12. PubMed ID: 19767206
[TBL] [Abstract][Full Text] [Related]
8. Carbon-11 labeled radioligands for imaging brain cannabinoid receptors.
Mathews WB; Scheffel U; Rauseo PA; Ravert HT; Frank RA; Ellames GJ; Herbert JM; Barth F; Rinaldi-Carmona M; Dannals RF
Nucl Med Biol; 2002 Aug; 29(6):671-7. PubMed ID: 12234592
[TBL] [Abstract][Full Text] [Related]
9. Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.
Li Z; Gifford A; Liu Q; Thotapally R; Ding YS; Makriyannis A; Gatley SJ
Nucl Med Biol; 2005 May; 32(4):361-6. PubMed ID: 15878505
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and preliminary biological evaluation of [123I]Me2Pyr, a new potential ligand for imaging of central cannabinoid CB1 receptors.
Gielow P; Klinge P; Knapp WH; Berding G
Appl Radiat Isot; 2006 Jul; 64(7):763-8. PubMed ID: 16554168
[TBL] [Abstract][Full Text] [Related]
11. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.
Gatley SJ; Gifford AN; Volkow ND; Lan R; Makriyannis A
Eur J Pharmacol; 1996 Jul; 307(3):331-8. PubMed ID: 8836622
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
[TBL] [Abstract][Full Text] [Related]
14. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors.
Wilson AA; Garcia A; Parkes J; McCormick P; Stephenson KA; Houle S; Vasdev N
Nucl Med Biol; 2008 Apr; 35(3):305-14. PubMed ID: 18355686
[TBL] [Abstract][Full Text] [Related]
15. Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as mu-opioid receptor imaging agents.
Henriksen G; Platzer S; Marton J; Hauser A; Berthele A; Schwaiger M; Marinelli L; Lavecchia A; Novellino E; Wester HJ
J Med Chem; 2005 Dec; 48(24):7720-32. PubMed ID: 16302812
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of [O-methyl-11C]1-(2-chlorophenyl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide: a potential PET ligand for CB1 receptors.
Kumar JS; Prabhakaran J; Arango V; Parsey RV; Underwood MD; Simpson NR; Kassir SA; Majo VJ; Van Heertum RL; Mann JJ
Bioorg Med Chem Lett; 2004 May; 14(10):2393-6. PubMed ID: 15109619
[TBL] [Abstract][Full Text] [Related]
17. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
[TBL] [Abstract][Full Text] [Related]
18. Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo.
Gatley SJ; Lan R; Volkow ND; Pappas N; King P; Wong CT; Gifford AN; Pyatt B; Dewey SL; Makriyannis A
J Neurochem; 1998 Jan; 70(1):417-23. PubMed ID: 9422389
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
[TBL] [Abstract][Full Text] [Related]
20. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Zhang W; Kung MP; Oya S; Hou C; Kung HF
Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
